← Back to Search

Home Telehealth with Video for HIV/AIDS

N/A
Recruiting
Led By Thomas P. Giordano, MD MPH
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
At least 18 years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial will test how well home telehealth services work when a video component is added for patients with HIV. The goal is to see if this will help them stay in care, which is crucial for managing their illness.

Who is the study for?
This trial is for adults over 18 with HIV who are patients at the Michael E. DeBakey VA Medical Center in Houston, TX. Participants must speak English and be able to consent to using Video to Home Telehealth services (VVC). Those with significant physical or mental disabilities preventing VVC use, or who are incarcerated, cannot join.Check my eligibility
What is being tested?
The study is testing how adding video calls (VVC) to home telehealth services affects the ability of HIV patients to stay engaged in their care. It aims to determine the effectiveness of this technology and how it can be implemented successfully.See study design
What are the potential side effects?
Since this trial involves a non-medical intervention (video calls), there aren't typical medication side effects. However, participants may experience issues related to privacy, technical difficulties, or discomfort with video communication.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Constancy retention in care measure
Secondary outcome measures
Adherence retention in care measure
Adherence to ART medications
Completed visits for adherence counseling
+1 more
Other outcome measures
AUDIT
CD4 cell count
HIV viral load
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: VVCExperimental Treatment1 Intervention
Option to receive VA Video Connect (VVC) delivery of HIV care.
Group II: Usual CareActive Control1 Intervention
All HIV care available at MEDVAMC will be delivered as usual.

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,611 Previous Clinical Trials
3,304,894 Total Patients Enrolled
Thomas P. Giordano, MD MPHPrincipal InvestigatorMichael E. DeBakey VA Medical Center, Houston, TX
Jan Alexandra Lindsay, PhDPrincipal InvestigatorMichael E. DeBakey VA Medical Center, Houston, TX

Media Library

VVC Clinical Trial Eligibility Overview. Trial Name: NCT04055207 — N/A
HIV/AIDS Research Study Groups: VVC, Usual Care
HIV/AIDS Clinical Trial 2023: VVC Highlights & Side Effects. Trial Name: NCT04055207 — N/A
VVC 2023 Treatment Timeline for Medical Study. Trial Name: NCT04055207 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the capacity of participants for this medical experiment?

"Affirmative. Information available on clinicaltrials.gov confirms that the subject trial published on July 1st 2021 and updated most recently on June 14th 2022 is currently in search of 390 patients at a single site."

Answered by AI

Is participation in this clinical trial accessible to prospective participants?

"The clinical trial is actively recruiting patients, as evidenced by the data on clinicaltrials.gov. The study was first registered in July 2021 and underwent its latest revision just days ago - June 14th 2022."

Answered by AI
~22 spots leftby Jun 2024